Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by gebremeskelon May 21, 2024 3:41pm
157 Views
Post# 36050618

RE:The BS pumpers have returned, which is not good news

RE:The BS pumpers have returned, which is not good newsWhich part are you disputing?

- the 140,000 patient target ?

- the potential 25% - 50% market penetration ?

- the 10X - 20X EBITDA multiple ?

- the 375M outstanding shares ?

Or are you just being ornery?

Forget the current Sshow - where is this thing likely to end up? Please present a coherent argument. Extra points if you can show your work.


Stocktree wrote:
for the SP in the medium term.

Apart from that, we can still see that this is the most off the market stock of all time, which cancels any predictions these stooges are trying to have us swallow.

As of now today, 323 501 shares were "traded". That little "1" at the end of the rather large volume for EDT is the only part of that "trading" that has made the needle move (by 1 cent and very briefly).

A total Sshow from beginning to end...




<< Previous
Bullboard Posts
Next >>